Medical Developments International Ltd Sustainability Reports
The company manufactures and distributes emergency medical and pain management solutions, notably the acute pain relief product Penthrox, alongside respiratory devices.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 9845007EAECAOD1U4493
FIGI: BBG001SFMT05
5 reports from 2022 to 2026
- Medical Developments International Ltd 2026 Preliminary Final Report
- Medical Developments International Ltd 2025 Corporate Governance Statement
- Medical Developments International Ltd 2025 Annual Report
- Medical Developments International Ltd 2023 Annual Report
- Medical Developments International Ltd 2022 Annual Report